Condition

Metastatic Hormone Sensitive Prostate Cancer clinical trials and research

• 9Clinical trials
• 23Countries

Newest Metastatic Hormone Sensitive Prostate Cancer clinical trials

All recruiting trials (9)

• JUR-003 in adults with advanced prostate cancer

  This first-in-human study tests JUR-003 to see if it is safe and tolerable and to get an early sense of activity in adults with metastatic or advanced prostate cancer.

  Recruiting at 4 sites Phase 1 TCG Labs Soleil · Grand Rapids, Michigan and 3 other locations · NCT07824349

• Tracking apalutamide use in men with metastatic hormone-sensitive prostate cancer in France

  This project will see if men with metastatic hormone-sensitive prostate cancer in France take apalutamide as prescribed during their first year of treatment.

  Recruiting Janssen Cilag S.A.S. · Caen · NCT07451002

• Darolutamide with hormone therapy (± chemotherapy) in metastatic hormone-sensitive prostate cancer

  This real-world study tests whether darolutamide plus hormone therapy, with or without chemotherapy, helps men with metastatic hormone-sensitive prostate cancer achieve very low PSA levels and stay safe.

  Recruiting at 10 sites Bayer · Many Locations and 15 other locations · NCT07344779

• ASP5541 with prednisone and ADT for Chinese men with prostate cancer

  This study tests whether giving ASP5541 together with prednisone and ongoing androgen-deprivation therapy is safe and how the medicine behaves in Chinese men with metastatic prostate cancer.

  Recruiting Phase 1 Astellas Pharma Inc · Beijing, Beijing Municipality · NCT07339267

• Intensifying Treatment With Docetaxel and Apalutamide for Metastatic Hormone-Sensitive Prostate Cancer After a Partial PSA Response

  This trial tests whether adding docetaxel to apalutamide and ADT helps men with metastatic hormone-sensitive prostate cancer who did not achieve a deep PSA response after initial apalutamide treatment.

  Recruiting Phase 3 Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD · Bayonne and 55 other locations · NCT07333066

• Phase 2 test of ASP5541 for men with advanced prostate cancer

  This study will test whether an injectable form of abiraterone (ASP5541) is safe and works as well or better than the standard oral abiraterone for men with metastatic prostate cancer who are on hormone therapy, with or without prednisone.

  Recruiting at 54 sites Phase 2 Astellas Pharma Inc · Huntsville, Alabama and 53 other locations · NCT07005154

• Observing the safety of darolutamide in Korean men with prostate cancer

  This study is testing the safety of darolutamide in Korean men with prostate cancer to see how well it works as part of their regular treatment.

  Recruiting Bayer · Many Locations · NCT06334120

• Combining JNJ-78278343 with other treatments for advanced prostate cancer

  This study is testing a new treatment called JNJ-78278343 combined with other therapies to see if it helps people with advanced prostate cancer feel better and stay safe.

  Recruiting at 15 sites Phase 1 Janssen Research & Development, LLC · Sarasota, Florida and 14 other locations · NCT05818683

• Investigating a new treatment for advanced prostate cancer

  This study is testing a new treatment for advanced prostate cancer to see if it is safe and how well it works for patients whose cancer has spread and is resistant to other therapies.

  Recruiting at 3 sites Phase 1/2 AdvanCell Pty Limited · Brisbane, Queensland and 2 other locations · NCT05720130

Related topics

Quick answers

How many Metastatic Hormone Sensitive Prostate Cancer clinical trials are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in France (4 trials), Spain (4 trials), Germany (3 trials), Italy (3 trials), United States (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 2: 1, Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →